SOUTH SAN FRANCISCO, Calif., Jan. 5, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, today announced the promotion of Gavin S. Choy, Pharm.D. and Alex Tkachenko, Ph.D. In their new roles, Dr. Choy will be responsible for all clinical operations as Vice President, Clinical Operations, while Dr. Tkachenko gains added responsibility overseeing Hana’s business development as Vice President, Corporate Development and Strategic Planning.
